This is a news story, published by Yahoo Finance, that relates primarily to Chris Schott news.
For more Chris Schott news, you can click here:
more Chris Schott newsFor more stocks trading & speculation news, you can click here:
more stocks trading & speculation newsFor more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best business news, entertainment news, world news, and much more. If you like stocks trading & speculation news, you might also like this article about
pharmaceutical portfolio. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest AI stock news, certain AI stocks news, stocks trading & speculation news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Best Dip StocksInsider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey
•Business
Business & Economics
74% Informative
On June 26 , J.P. Morgan analyst Chris Schott maintained their Hold Rating on Johnson & Johnson ( NYSE : JNJ ) with a price target of $ 185 .
Schott acknowledged that the company’s underlying business is well-positioned for over 5% sustained top-line growth.
However, he also noted some key challenges that temper his optimism.
VR Score
69
Informative language
64
Neutral language
36
Article tone
formal
Language
English
Language complexity
56
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
4
Source diversity
1
Affiliate links
no affiliate links